Commenting on the expansion, Cromos managing director Dr Andrey Tarakanov said, "The staff of our Smolensk office has considerable experience in all stages of clinical trial conduct in Belarus, and Cromos Pharma has a strong working relationship with local medical centers and investigators."
The company offers a range of trial-related services, including regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing.
Cromos Pharma chief executive officer Dr Vladimir Bogin said, "Belarus has a developed healthcare system, well-trained medical professionals with good knowledge of ICH/GCP and standards of care that are comparable to European medical practice."